Vaccination, rheumatological diseases, immunosuppression, infection prevention, evidence-based medicine
Keywords:
Vaccination, rheumatological diseases, immunosuppression, infection prevention, evidence-based medicineAbstract
Autoimmune rheumatological diseases predispose individuals to a higher risk of preventable infections, due to both inherent immune dysfunction and the use of immunosuppressive therapies. Despite the existence of robust clinical guidelines from organizations such as EULAR, IDSA, and ACR, vaccination in this population continues to be underestimated and poorly implemented. This letter highlights the main barriers to effective immunization in patients with rheumatological diseases and proposes concrete strategies for clinical practice to improve vaccination coverage, especially in middle-income countries like Colombia. It emphasizes the need to integrate vaccination prevention as an essential component of comprehensive rheumatological management, with a focus on equity and evidence-based medicine.
Downloads
References
van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70(3):414–422. doi:10.1136/ard.2010.137216
Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79(1):39–52. doi:10.1136/annrheumdis-2019-215882
Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–318. doi:10.1093/cid/cit684
Curtis JR, Johnson SR, Anthony DD, et al. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2021;73(8):1093–1107. doi:10.1002/art.41734
Machado PM, Lawson-Tovey S, Strangfeld A, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR COVID-19 Vaccine Registry. Ann Rheum Dis. 2022;81(6):695–709. doi:10.1136/annrheumdis-2021-221125
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Juan Sebatian Theran León, Andrés Felipe Otero Rueda
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
